Development and Optimization of 111In-Dinutuximab-IRDye800, a Dual-Modality Intraoperative Molecular Imaging Agent for Pediatric Neuroblastoma Resection
Catherine Yip, Lauren Taylor Rosenblum, Arjun Pant, Arianna Kahler‐Quesada, Bhuvitha Chagantipati, ReidAnn E. Sever, Brady Grano-Mickelsen, Bo Li, Angel G. Cortez, Joseph D. Latoche, Kathryn E. Day, Lora Heather Rigatti, Jessie R. Nedrow, Barry W Edwards, Gary Kohanbash, Marcus M. Malek
This paper develops and optimizes 111In-Dinutuximab-IRDye800, a dual-modality imaging agent for neuroblastoma resection, finding that an optimal dose and ratio maximize tumor detection.
bioRxiv · Aug 31, 2026 · PreprintCancer Biology